Welcome to our dedicated page for GABELLI DIVIDEND & INCOME TRUST SEC filings (Ticker: GDV), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on GABELLI DIVIDEND & INCOME TRUST's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into GABELLI DIVIDEND & INCOME TRUST's regulatory disclosures and financial reporting.
The Gabelli Dividend & Income Trust is soliciting proxies for its Annual Meeting to be held in 2026 amid a contested trustee election initiated by Saba Capital Master Fund, Ltd. The Board urges shareholders to return the enclosed WHITE proxy card and states it does not endorse Saba’s Hedge Fund Nominee. The record date shows 87,446,297 Common Shares and Preferred series outstanding, including 7,617,018 Common Shares (8.7%) held by Morgan Stanley and 5,197,810 Common Shares (5.9%) held by Saba Capital Management, L.P.; GAMCO-affiliates hold 17,130,000 Preferred Shares (58.5%). Four Trustees are up for election (three by Common+Preferred together; one by Preferred alone). The Board cautions that returning a proxy sent by Saba may disenfranchise a shareholder from electing the full slate and emphasizes that only the most recently dated proxy will be counted.
GDV submitted an N-CEN annual report template-style filing that lists operational items and periodic schedules for a registered investment company. The filing excerpt shows aggregate brokerage commissions of $410,507 and multiple principal-transaction values, including a $577,053,414 counterparty trading total, with other dealer totals also reported.
The form records service-provider sections (advisers, custodians, transfer agents), securities-lending and rule-exemption checklists, and space for directors, compliance officer, and signature blocks; many fields in the excerpt are left as form entries rather than completed disclosures.
Saba Capital is soliciting proxies to elect Andre Clemot to the board of The Gabelli Dividend & Income Trust at the 2026 annual meeting. Saba reports beneficial ownership of 5,207,566 Common Shares (5.91%) based on 88,167,468 Common Shares outstanding as of December 31, 2025.
Saba cites the Fund’s trading discount to NAV of -11.92% as of March 9, 2026 (three-year average -13.90%) and urges shareholders to return the enclosed GOLD proxy card voting FOR the Nominee. The Nominee does not beneficially own Fund securities and would, if elected, serve as one of thirteen trustees.
The Gabelli Dividend & Income Trust (GDV) filed its Form N-CSR certified shareholder report for the fiscal year ended December 31, 2025, presenting audited financial statements, a schedule of investments, and performance results.
For the year, the Fund’s NAV total return was 17.9% and the market (investment) total return was 22.7%. NAV per share was $30.76 and the NYSE closing price was $27.77. The report discloses portfolio composition, asset allocation, net investment income of $16,210,793, and net realized and unrealized gains totaling $413,167,232.
GABELLI DIVIDEND & INCOME TRUST reported the initial insider status of Colin J. Kilrain on a Form 3. The filing identifies him as a director of the fund. The provided data does not list any reportable transactions or share holdings for him in this filing.
GABELLI DIVIDEND & INCOME TRUST director Mario J. Gabelli reported an indirect open-market purchase of 4,500 common shares at $29.0933 per share through GGCP, Inc.
After this trade, GGCP is shown with 25,000 shares, Gabelli directly holds 145,812 shares, and Associated Capital Group, Inc. is shown with 626,000 shares. The filing states Gabelli is the controlling shareholder of GGCP and ACG and disclaims beneficial ownership beyond his indirect pecuniary interest.
Morgan Stanley and its affiliate Morgan Stanley Smith Barney LLC filed an amended Schedule 13G reporting a significant position in Gabelli Dividend & Income Trust common stock as of 12/31/2025. Morgan Stanley reports beneficial ownership of 7,617,018 shares, representing 8.6% of the outstanding common stock, with shared voting and dispositive power.
The filing states the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of the trust. It also notes that the disclosure reflects only certain Morgan Stanley reporting units, with other units disaggregated under SEC guidance.
Gabelli Dividend & Income Trust director Anthony S. Colavita reported a purchase of common shares. On 02/09/2026, he acquired 684 common shares at a price of $29.1959 per share. Following this transaction, he directly owns 684 common shares of the trust.
Gabelli Dividend & Income Trust insider filing reports an indirect share purchase through a controlled entity. On 01/27/2026, GGCP, Inc., an entity controlled by Mario J. Gabelli, purchased 5,500 common shares of Gabelli Dividend & Income Trust at $28.7174 per share, bringing GGCP’s reported holdings to 20,500 shares.
The Form 4 also shows Mario J. Gabelli with 145,812 common shares held directly and 626,000 common shares held indirectly through Associated Capital Group, Inc. He is the controlling shareholder of both GGCP and Associated Capital Group and disclaims beneficial ownership beyond his indirect pecuniary interest.
Gabelli Dividend & Income Trust director Elizabeth C. Bogan reported buying 400 common shares at $28.7299 per share. This purchase on January 27, 2026 brought her directly held stake in the fund to 400 common shares, according to the Form 4 insider trading report.